Pharmacists in New Brunswick, New Jersey


60 Pharmacists found in New Brunswick
female pharmacist

See Gin Lee


Pharmacist
366 George St, New Brunswick, NJ 08901
732-247-2331    

female pharmacist

Shivani Balyan


Pharmacist
20 Jersey Ave, New Brunswick, NJ 08901
732-846-9360    

female pharmacist

Soumya Jairam, PHARMD


Pharmacist
1 Robert Wood Johnson Pl, New Brunswick, NJ 08901
732-246-1745    



male pharmacist

Mr. Stanley Boro, RPH


Pharmacist
366 George St, New Brunswick, NJ 08901
732-247-2331     732-846-1164

female pharmacist

Sydney Therese Declaro, RPH


Pharmacist
20 Jersey Ave, New Brunswick, NJ 08901
732-846-9360    

female pharmacist

Tejasvi Patel


Pharmacist
159 French St, New Brunswick, NJ 08901
732-418-1100     732-418-1109

female pharmacist

Teresa Direnzo Berkowicz, PHARMD


Pharmacist
125 Paterson St, New Brunswick, NJ 08901
732-235-8558     732-235-8658

female pharmacist

Thom Nguyen


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
5 Dennis St Apt 109, New Brunswick, NJ 08901
732-776-4711    

female pharmacist

Vivianne Celario, PHARM D.


Pharmacist
1 Robert Wood Johnson Pl, New Brunswick, NJ 08901
732-246-1745     732-418-7923

female pharmacist

Xinyuan Hu, PHARM D


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
1 Robert Wood Johnson Pl, New Brunswick, NJ 08901
732-246-1745     732-418-7923

female pharmacist

Yae Eun Chong, PHARMD


Pharmacist
20 Jersey Ave, New Brunswick, NJ 08901
732-846-9360    

female pharmacist

Yostina Shaker


Pharmacist
121 French St, New Brunswick, NJ 08901
732-448-9444     732-448-9333


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.